XML 39 R21.htm IDEA: XBRL DOCUMENT
v3.25.1

SHAREHOLDERS' EQUITY | 12 Months Ended
--- | ---
Dec. 31, 2024
Stockholders' Equity Note [Abstract] |
SHAREHOLDERS' EQUITY |
NOTE 13: - | SHAREHOLDERS' EQUITY
| a. | Company's shares: As of December 31, 2024, the Company's authorized share capital consists of NIS 20,000,000 divided into 200,000,000 Ordinary Shares, par value NIS 0.1 per share. Ordinary Shares confer on their holders the right to receive notice to participate and vote in general meetings of the Company, the right to a share in the excess of assets upon liquidation of the Company, and the right to receive dividends if declared.
| b. | Share option plan: A summary of the Company's share option activity, pertaining to its option plans for employees and related information is as follows:
|  | Year ended December 31, |
|  | 2024 |  |  | 2023 |  |  | 2022 |
|  | Number of shares upon exercise |  |  | Weighted average exercise price |  |  | Number of shares upon exercise |  |  | Weighted average exercise price |  |  | Number of shares upon exercise |  |  | Weighted average exercise price |
Outstanding at beginning of year |  |  | 413,995 |  |  | $ | 5.44 |  |  |  | 487,839 |  |  | $ | 5.96 |  |  |  | 675,986 |  |  | $ | 7.99 |
Granted |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |
Forfeited |  |  | (353,745 | ) |  | $ | 5.35 |  |  |  | (72,480 | ) |  | $ | 9.04 |  |  |  | (139,494 | ) |  | $ | 16.08 |
Exercised |  |  | (250 | ) |  | $ | 5.16 |  |  |  | (1,364 | ) |  | $ | 0.03 |  |  |  | (48,653 | ) |  | $ | 5.01 |
Outstanding at end of year |  |  | 60,000 |  |  | $ | 5.94 |  |  |  | 413,995 |  |  | $ | 5.44 |  |  |  | 487,839 |  |  | $ | 5.96 |
Exercisable at end of year |  |  | 60,000 |  |  | $ | 5.94 |  |  |  | 413,995 |  |  | $ | 5.44 |  |  |  | 487,839 |  |  | $ | 5.96 |
Vested and expected to vest |  |  | 60,000 |  |  | $ | 5.94 |  |  |  | 413,995 |  |  | $ | 5.44 |  |  |  | 487,839 |  |  | $ | 5.96 |
|  | The aggregate intrinsic value represents the total intrinsic value (the difference between the Company's closing share price on the last trading day of the fiscal years 2024, 2023 and 2022 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders if all option holders exercised their options on December 31, 2024, 2023 and 2022, respectively. This amount may change based on the fair market value of the Company's share. The total intrinsic value of options outstanding as of December 31, 2024, 2023 and 2022, were $ 1, $ 0 and $ 10, respectively. The total intrinsic value of exercisable options as of December 31, 2024, 2023 and 2022, were approximately $ 1, $ 1 and $ 10 , respectively. The total intrinsic value of options vested and expected to vest as of December 31, 2024, 2023 and 2022, were approximately $ 1, $ 0 and $ 10, respectively. The total intrinsic value (the difference between the Company's closing share price on the exercise date and the exercise price) of options exercised during the years ended December 31, 2024, 2023 and 2022 were approximately $ 0, $ 93 and $ 93 , respectively. The number of options vested during the year ended December 31, 2024 was 0. The weighted-average remaining contractual life of the outstanding options as of December 31, 2024 is 0.68 years. The weighted-average remaining contractual life of exercisable options as of December 31, 2024 is 0.68 years.
|  | The following provides a summary of the restricted share unit activity for the Company for the two years ended December 31, 2024:
|  | Year ended December 31, |
|  | 2024 |  |  | 2023 |
|  | Number of shares upon exercise |  |  | Weighted average share price |  |  | Number of shares upon exercise |  |  | Weighted average share price |
Outstanding at beginning of year |  |  | 2,263,699 |  |  | $ | 4.95 |  |  |  | 2,255,620 |  |  | $ | 8.52 |
Granted |  |  | 2,531,837 |  |  | $ | 2.44 |  |  |  | 1,330,500 |  |  | $ | 2.47 |
Vested |  |  | (1,153,804 | ) |  | $ | 2.21 |  |  |  | (1,005,532 | ) |  | $ | 2.19 |
Forfeited |  |  | (594,291 | ) |  | $ | 3.47 |  |  |  | (316,889 | ) |  | $ | 2.38 |
Unvested at end of year |  |  | 3,047,441 |  |  | $ | 2.69 |  |  |  | 2,263,699 |  |  | $ | 4.95 |
|  | As of December 31, 2024, $ 6,026 unrecognized compensation cost related to RSUs is expected to be recognized over a weighted average vesting period of 1.64 years. Under the terms of the above option plans, options may be granted to employees, officers, directors and various service providers of the Company and its subsidiaries. The options vest over a four -year period, subject to the continued employment of the employee. The options generally expire no later than ten years from the date of the grant. The exercise price of the options at the date of grant under the plans may not be less than the nominal value of the shares into which such options are exercised, any options, which are forfeited or cancelled before expiration, become available for future grants. As of December 31, 2024, 13,023 Ordinary shares are available for future issuance under the option plans. The Company granted 2,531,837 and 1,330,500 RSUs in 2024 and 2023, respectively under the 2016 option plan. RSUs vest over a period of between one year to four years, subject to the continued employment of the employee. RSUs that are cancelled or forfeited become available for future grants.

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for equity. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 235 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 235 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(e)(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1 Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/505/tableOfContent Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 16 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration